Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 38 Immune Landscape Signatures

As part of a broad immuno-oncology assay portfolio, Q2 Solutions offers gene expression and analysis services for the detection of Immune Landscape Signatures attributable to 38 key immune cell subtypes, immune functions, individually important immune-related genes and ratios.

Results for the individual signatures are output as Immune Landscape Signature Scores, non-standardized and standardized across the project and can be used to determine immunogenic status of solid tumors. These signatures can also be used in a single-or multi-factor analysis of treatment response and survival, along with other clinicopathological and genomic co-factors such as tumor mutational burden.

Download factsheet to learn more about product highlights and deliverables.